Lataa...
High mutation burden of circulating cell‐free DNA in early‐stage breast cancer patients is associated with a poor relapse‐free survival
BACKGROUND: High tumor mutation burden is shown to be associated with a poor clinical outcome. As the tumor‐derived fraction of circulating cell‐free DNA (cfDNA) is shown to reflect the genetic spectrum of the tumor, we examined whether the mutation burden of cfDNA could be used to predict the clini...
Tallennettuna:
| Julkaisussa: | Cancer Med |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7433819/ https://ncbi.nlm.nih.gov/pubmed/32602248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3258 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|